Cellular Dynamics International, Harvard Stem Cell Institute to collaborate
Thursday, April 20, 2017
Cellular Dynamics International (CDI), a FUJIFILM company and a developer and manufacturer of induced pluripotent stem cells (iPS), has signed a collaboration agreement with the Harvard Stem Cell Institute (HSCI), a novel network of stem cell scientists that extends from the University to its affiliated hospitals and the biomedical industry. The objective of the new partnership is to increase the availability of iPS cells and services to the HSCI network and the research community at large.
“CDI is honored and excited to partner with Harvard Stem Cell Institute, one of the world’s most prestigious research organizations,” said Dr. Bruce Novich, division president-CNBD for FUJIFILM Holdings America Corporation and Executive Vice President and General Manager of Life Science Business Division for CDI. “Our goal is to make iPS cells and technology more accessible so that researchers across disciplines and the various institutions of HSCI can better pursue the promise of stem cell science and regenerative medicine.”
Under the terms of the agreement, CDI will collaborate with HSCI’s iPS Core Facility by providing iPSC technology support to the stem cell community. In addition, CDI will offer critical iPSC technology elements which may accelerate iPSC based science, technology and applications.